Key points are not available for this paper at this time.
Day -case implant -based immediate breast reconstruction IBR represents a feasible and safe approach in selected breast cancer patients. This retrospective cohort study examined 46 procedures conducted between January 2019 and 2022, focusing on various factors, including patient demographics, comorbidities, types of mastectomies, and complications. Results revealed that 41 (89%) of patients were successfully discharged on the same day, with 10 experiencing postoperative complications, such as hematoma and implant loss. These rates were below national standards, demonstrating the potential for day -case IBR as a viable option. Key factors contributing to success included preoperative patient education, effective postoperative pain management, and the support of a dedicated community healthcare team. This study underscores the significance of tailored patient care and comprehensive protocols in enhancing the feasibility of day -case IBR for breast cancer patients.
Sandhya et al. (Tue,) studied this question.